Pleasure Balm Gel
NDC Package 56152-1470-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Pleasure Balm (benzocaine) gel is discontinue use and consult a doctor ifThis product, used as directed does not provide reliefYou or your partner develops a rash or irritation, such as burning or itchingCondition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few daysThe following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue colored skin as these may be signs of methemoglobinemia, a rare disorder which may appear up to 2 hours of use. This formulation utilizes a gel delivery system. Marketed by Cosmetic Enterprises Ltd, this product is identified by NDC 56152-1470 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
56152-1470-1
Package Description
12 mL in 1 TUBE
Product Code
56152-1470
11-Digit Billing Format
56152147001

Clinical Specifications

Proprietary Name
Pleasure Balm Kama Sutra
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
BENZOCAINE 5 g/100mL
Pharmacologic Class
Usage Information
Discontinue use and consult a doctor ifThis product, used as directed does not provide reliefYou or your partner develops a rash or irritation, such as burning or itchingCondition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few daysThe following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue colored skin as these may be signs of methemoglobinemia, a rare disorder which may appear up to 2 hours of use

Regulatory & Marketing

Labeler Name
Cosmetic Enterprises Ltd
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-12-2013
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 56152-1470-1 identifies a specific commercial package of 12 ml in 1 tube of Pleasure Balm Kama Sutra, a human over the counter drug labeled by Cosmetic Enterprises Ltd. This gel is formulated for topical use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cosmetic Enterprises Ltd on September 12, 2013. The current certification is valid through December 31, 2026.

How is this Cosmetic Enterprises Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 56152147001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
56152-1470-1
11-Digit CMS (5-4-2)
56152-1470-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.